Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Applied DNA Sciences, Inc. - Common Stock (NQ:APDN)

5.620 UNCHANGED
Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Applied DNA Sciences, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
Applied DNA to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
Applied DNA Executes LOI with Spindle Biotech for Research Collaboration on Simplified High Yield mRNA Production System
From Applied DNA Sciences, Inc. and Spindle Biotech Inc.
Via Business Wire
News headline image
Applied DNA Raises $4.2M Via Registered Direct Offering ↗
Applied DNA Sciences, Inc. (NASDAQ:APDN) a polymerase chai... 
Via Benzinga
News headline image
Applied DNA Sciences To Raise $4.2M Via Registered Direct Offering ↗
Applied DNA Sciences, Inc. (NASDAQ:APDN), a polymera... 
Via Benzinga
News headline image
Earnings Scheduled For February 10, 2022 ↗
Companies Reporting Before The Bell • Canada Goose Hldgs (NYSE:GOOS) is projected to report quarterly earnings at $1.46 per share on revenue of $584.49 million. 
Via Benzinga
InvestorNewsBreaks — Applied DNA Sciences Inc. (NASDAQ: APDN) Closes on $4.2M Registered Direct Offering
Via Investor Brand Network
News headline image
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million.... 
Via Benzinga
News headline image
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers Creative Medical Tech (NASDAQ:CELZ 
Via Benzinga
News headline image
Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA™ Platform Approach to Cancer Immunotherapy
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
Looking Into Applied DNA Sciences's Return On Capital Employed ↗
Applied DNA Sciences (NASDAQ:APDN) brought in sales totaling $4.17 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 4.73%, resulting in a loss of $4.72... 
Via Benzinga
News headline image
78 Biggest Movers From Friday ↗
Gainers Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab. China Online Education... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Avenue Therapeutics (NASDAQ:ATXI... 
Via Benzinga
News headline image
52 Weeks High And Low Article ↗
On Friday, 106 companies reached new 52-week lows. Things to Consider About Today's 52-Week Lows: Air Products & Chemicals (NYSE:APD) is the largest company... 
Via Benzinga
News headline image
41 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday. Kaival Brands Innovations... 
Via Benzinga
News headline image
Recap: Applied DNA Sciences Q1 Earnings ↗
Applied DNA Sciences (NASDAQ:APDN) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Applied DNA First Quarter Fiscal 2022 Financial Results Feature Record Quarterly Revenues
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
Applied DNA Schedules Fiscal 2022 First Quarter Financial Results Conference Call and Webcast for Thursday, February 10, 2022
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
Applied DNA to Deploy Linea™ 1.0 COVID-19 Assay for Rapid Detection of New Omicron Subvariant BA.2
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
Applied DNA Submits Request for Emergency Use Authorization to FDA for Linea™ 2.0 COVID-19 Assay and Linea™ Unsupervised At-Home Sample Collection Kit
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
Applied DNA Announces Continued Momentum in COVID-19 Testing Demand
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
Applied DNA Receives New York State Department of Health Conditional Approval for Linea™ 2.0 COVID-19 Assay as Laboratory Developed Test
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
Applied DNA and Stratum Reservoir (Isotech) Sign Memorandum of Understanding to Leverage Isotopic Analysis for Enhanced DNA-Based Cotton Authenticity and Provenance
From Applied DNA Sciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers Quoin Pharmaceuticals (NASDAQ: 
Via Benzinga
News headline image
Applied DNA Sciences Earnings Perspective: Return On Capital Employed ↗
Benzinga Pro data, Applied DNA Sciences (NASDAQ:APDN) reported Q4 sales of $3.00 million. Earnings fell to a loss of $4.51 million, resulting in a 30.78% decrease from last... 
Via Benzinga
News headline image
18 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Context Therapeutics Inc. (NASDAQ: CNTX) rose 48.6% to $9.30 in pre-market trading as the company announced data from ONA-XR in early breast cancer. The company said ONA-... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Angion Biomedica's ANG-3777 Does Not Meet Primary Endpoint In Mid-Stage... 
Via Benzinga
News headline image
Applied DNA Sciences' Q4 Revenues Skyrockets Buoyed By Momentum In COVID-19 Diagnostic Testing ↗
Applied DNA Sciences Inc (NASDAQ: APDN) reported a more than ninefold Y/Y increase in Q4 FY21 revenues, driven by the rise in clinical laboratory service revenues related to... 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.